First evaluations of LPV/RTV(Kaletra) efficacy on HIV-positive patients treated with multiple drugs;Prime valutazioni sull'efficacia di LPV/RTV (Kaletra) in una casistica di pazienti HIV+ pluritrattati

Infezioni in Medicina

Volumn 11, Issue 1, 2003, Pages 18-24

  Sabbatani, Sergio ^a   Legnani, Giorgio ^a   Fulgaro, Ciro ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

HIV follow up; Lopinavir; Ritonavir

Indexed keywords

CD4 ANTIGEN; LOPINAVIR PLUS RITONAVIR;

ADULT; ALLERGY; ARTICLE; CONTROLLED STUDY; CYTOFLUOROMETRY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER TOXICITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NAUSEA; VIREMIA; VIRUS LOAD;

ADULT; ANTI-HIV AGENTS; FEMALE; HIV SEROPOSITIVITY; HUMANS; MALE; PYRIMIDINONES; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0037269395     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Palella F.J., Delaney K.M., Moorman A.C. et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N. Engl. J. Med. 853-860, 338, 1998.
2. Mocraft A., Vella S., Benfield T.L. et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Euro SIDA Study Group. Lancet 352, 1725-1730, 1998.
3. Mocroft A., Katlama C., Johnson A.M. et al. The changing spectrum of AIDS across Europe 1994-1998. Results from the Euro Sida study. Lancet 356, 291-296, 2000.
4. Gordillo V., del Amo J., Soriano V., Gonzalez-Lahoz J. Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS 13, 1763-1769, 1999.
5. Gifford A.L., Bormann J.E., Shiveley M.J., Wright B.C., Richmann D.D., Bozzette S.A. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. J. Acquir. Immune Defic. Syndr. 23, 386-395, 2000.
6. Catz S.L., Kelly J.A., Bogart L.M., Benotsch E.G., McAuliffe T.L., Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 19, 124-133, 2000.
7. Di Matteo M.R., Lepper H.S., Croghan T.W. Depression is a risk factor for non compliance with medical treatment: meta-analysis of the effect of anxiety and depression on patient adherence. Arch. Intern. Med. 160, 2101-2107, 2000.
8. Paterson D.L., Swindells S., Mohr J. et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann. Intern. Med., 133, 21-30, 2000.
9. Molla A., Korneyeva M., Gao S. et al. Ordered accumulation of mutations in HIV protease confers resistance to ritonavir. Nat. Med. 2, 760-766, 1996.
10. th Conference on Retroviruses and Opportunistic Infections, Washington, USA, January 22-26, 1997.
11. Nelson M. Boosted vs non-boosted Pls. Aiming for long-term success, pg. 7. Prague. April 26-27, 2002. Scientific Symposium on HIV management sponsored by Abbott Laboratories.
12. AIDS Alert - febbraio 2002. American Healts Consultants. Edizioni di Medical Economics Data Italia.
13. Sherer R. Real-world clinical experience with Kaletra Aiming for long-term success, pg. 16-17. Prague April 26-27, 2002. Scientific Symposium on HIV management sponsored by Abbott Laboratories.
14. Jaeger H. Real-world clinical experience with Kaletra. Aiming for long-term success. Pg. 18-19. Prague April 18-19 2002. Scientific Symposium on HIV management sponsored by Abbott Laboratories.
15. Murphy R.L., Brun S., Hicks C. et al. ABT 378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naïve adults with HIV-1 infection: 48 week results. AIDS 15, 1-9, 2001.
16. st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois. December 2001.
17. th European Conference on Clinical Aspects and Treatment of HIV-Infection. Athens, Greece. October 2001.
18. th European Conference on Clinical Aspects and Treatment of HIV-Infection. Athens, Greece, October 2001.
19. th European Conference on Clinical Aspects and Treatment of HIV-Infection, Athens, Greece. October 2001.
20. th European Conference on Clinical Aspects and Treatment of HIV-Infection, Athens, Greece, October 2001.